- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 17.9M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $0 |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $2.08M |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $293.06M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $248.6M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $58.6M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $44.82M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $361.12M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $302.97M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $259.01M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $198.21M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $564.55M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $493.35M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | $0.79 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.63 |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 20.17M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $1.15M |
| Capex | Q1 2025 · Mar 31, 2024 | $366K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $22.64M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $130.9M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $117.89M |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.68 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $29.08M |
| Net Income | Q1 2025 · Mar 31, 2024 | $12.01M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $19.27M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $48.35M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $34.71M |